IL2 and neoplasm: Upon addition of rimiducid, a lipid-permeable dimerizing ligand, CD40 and MyD88 are activated to induce effector cytokine production (GM-CSF, IFN-γ, TNF-α, IL-2)Antigen-independent enhanced survival and proliferationImproved tumor control